ANCA-associated vasculitis

AR Kitching, HJ Anders, N Basu, E Brouwer… - Nature reviews Disease …, 2020 - nature.com
The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a
group of disorders involving severe, systemic, small-vessel vasculitis and are characterized …

[HTML][HTML] Eosinophils in health and disease: a state-of-the-art review

ME Wechsler, A Munitz, SJ Ackerman, MG Drake… - Mayo Clinic …, 2021 - Elsevier
Eosinophils play a homeostatic role in the body's immune responses. These cells are
involved in combating some parasitic, bacterial, and viral infections and certain cancers and …

Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis

G Emmi, A Bettiol, E Gelain, IM Bajema… - Nature Reviews …, 2023 - nature.com
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic
antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and …

[HTML][HTML] Eosinophilic granulomatosis with polyangiitis: a review

JPE White, S Dubey - Autoimmunity Reviews, 2023 - Elsevier
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, multi-system, inflammatory
disease, belonging to the group of anti-neutrophil cytoplasmic antibody (ANCA)-associated …

Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study

A Bettiol, ML Urban, L Dagna, V Cottin… - Arthritis & …, 2022 - Wiley Online Library
Objective Mepolizumab proved to be an efficacious treatment for eosinophilic
granulomatosis with polyangiitis (EGPA) at a dose of 300 mg every 4 weeks in the …

Update on eosinophilic granulomatosis with polyangiitis

S Furuta, T Iwamoto, H Nakajima - Allergology International, 2019 - jstage.jst.go.jp
abstract Eosinophilic granulomatosis with polyangiitis (EGPA)(formerly Churg-Strauss
syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis …

[HTML][HTML] EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update

B Hellmich, B Sanchez-Alamo, JH Schirmer… - Annals of the …, 2024 - ard.bmj.com
Background Since the publication of the EULAR recommendations for the management of
antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several …

From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases

ID Pavord, EH Bel, A Bourdin, R Chan, JK Han… - Allergy, 2022 - Wiley Online Library
Effective treatment of inflammatory diseases is often challenging owing to their
heterogeneous pathophysiology. Understanding of the underlying disease mechanisms is …

Oral corticosteroids stewardship for asthma in adults and adolescents: a position paper from the Thoracic Society of Australia and New Zealand

J Blakey, LP Chung, VM McDonald, L Ruane… - …, 2021 - Wiley Online Library
Oral corticosteroids (OCS) are frequently used for asthma treatment. This medication is
highly effective for both acute and chronic diseases, but evidence indicates that …

Eosinophilic granulomatosis with polyangiitis–advances in pathogenesis, diagnosis, and treatment

J Fijolek, E Radzikowska - Frontiers in Medicine, 2023 - frontiersin.org
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare disease characterized by
eosinophil-rich granulomatous inflammation and necrotizing vasculitis, pre-dominantly …